Skip to main content
. 1997 Jan 15;17(2):735–744. doi: 10.1523/JNEUROSCI.17-02-00735.1997

Table 1.

Abbreviations of agents used

Abbreviation(s) Agent Action
PGE2or E2 Prostaglandin E2 Hyperalgesic inflammatory mediator
DAMGO or D [d-Ala2,N-Me-Phe4,gly5-ol] enkephalin μ-opioid receptor agonist
N Naloxone Opioid receptor antagonist
Cl Clonidine α2-adrenergic agonist
Yo Yohimbine α2-adrenergic antagonist
CPA N6-cyclopentyl-adenosine A1-adenosine receptor agonist
PACPX 1,3-dipropyl-8-(2-amino-4-chlorophenyl)-xanthine A1-adenosine receptor antagonist
μ-antisense μ-opioid receptor oligodeoxynucleotide (ODN) Downregulation of μ-opioid receptors
μ-sense No effect
α2-antisense α2C-adrenergic receptor oligodeoxynucleotide (ODN) Downregulation of α2C-adrenergic receptors
α2-sense No effect